The ratio of Pn expression in breast cancer tissue to NAT was higher in hPn-ASVs with exon 21 than all hPn-ASVs by 1.6–5.2-fold in four patients and lower in two patients (by 0.5- and 0.8-fold, respectively; Figure 5E). The gene discussed is HPN; the disease is breast carcinoma.